These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16117145)

  • 1. [Efficacy of keppra in combined therapy in pharmacoresistant adult epilepsy patients].
    Karlov VA; Vlasov PN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):38-44. PubMed ID: 16117145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of the two-year experience of using keppra in therapy of adult patients with epilepsy].
    Karlov VA; Vlasov PN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):24-30. PubMed ID: 16921715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
    Karlov VA; Freĭdkova NV; Rusanova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):37-9. PubMed ID: 22983238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of non-superiority: what do we know after KOMET?
    Sönnichsen AC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1067. PubMed ID: 23123641
    [No Abstract]   [Full Text] [Related]  

  • 12. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
    Leppik IE; Biton V; Sander JW; Wieser HG
    Epilepsia; 2003 Dec; 44(12):1585-7. PubMed ID: 14636332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
    Aĭvazian SO; Shiriaev IuS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):33-8. PubMed ID: 22500310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L; Buyse G; Ceulemans B
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam--a new drug for epilepsy.
    Drug Ther Bull; 2002 Apr; 40(4):30-2. PubMed ID: 11995265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use.
    Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
    J Child Neurol; 2005 Jul; 20(7):590-4. PubMed ID: 16159526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.